Conference Call Participants
Jinpeng He – Citic Securities Co., Ltd., Research Division
Jian Wang
Fuk Lung Cheung – Citigroup Inc., Research Division
Kewei Chen – Haitong International Research Limited
Presentation
Operator
Ladies and gentlemen, thank you for standing by for So-Young’s Second Quarter 2026 Earnings Conference Call. [Operator Instructions] As a reminder, today’s conference call is being recorded. I would now like to turn the meeting over to your host for today’s call, Ms. Mona Qiao. Please proceed, Mona.
Mona Qiao
Investor Relation Officer
Thank you, operator, and thank you, everyone, for joining So-Young’s Second Quarter 2026 Earnings Conference Call. Joining the call today are Mr. Xing Jin, our Founder, Chairman and CEO; and Ms. Shannon Shen, our CFO. Before we begin, please refer to the safe harbor statement in our earnings release, which applies to this call and we will be making forward-looking statements. We will also discuss non-GAAP financial measures. Reconciliations between GAAP and non-GAAP measures are included in today’s earnings press release.
Please also note, all figures mentioned in this call are in RMB, unless otherwise stated. With that, I’d like to turn the call over to Mr. Xing Jin.
Xing Jin
Co-Founder, CEO & Chairman
[Foreign Language].
Mona Qiao
Investor Relation Officer
[Interpreted] Hello, everyone, and welcome to today’s earnings call. In Q2 2026, we continue to expand our aesthetic treatment business, guided by our scale and efficiency backed by our ever-improving medical capabilities, a uniform delivery framework and wider AI adoption. The business enhanced its operational ability and delivered a robust performance. Its Q2 revenue reached RMB 330 million, up roughly 130% year-over-year, beating the upper end of guidance by about 5%. As a result, group revenue
